Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Emory University
Ohio State University Comprehensive Cancer Center
National Medical Research Radiological Centre of the Ministry of Health of Russia
NRG Oncology
University of California, San Diego
Sir Mortimer B. Davis - Jewish General Hospital
Washington University School of Medicine
Centre hospitalier de l'Université de Montréal (CHUM)
University of Utah
Sun Yat-sen University
University of Leipzig
Fudan University
George Washington University
Fudan University
Abramson Cancer Center at Penn Medicine
Fudan University
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Nova Scotia Health Authority
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Iowa
Dana-Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
Azienda USL 4 Prato
Burzynski Research Institute
University of Zurich
Roswell Park Cancer Institute
University of Michigan Rogel Cancer Center
University of Leipzig
University of Alabama at Birmingham
University of Chicago
Heidelberg University
Roswell Park Cancer Institute
Fundacion Miguel Servet
Groupe Oncologie Radiotherapie Tete et Cou